Literature DB >> 6158242

Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.

R P Wilkin, N Bruchovsky, T K Shnitka, P S Rennie, T L Comeau.   

Abstract

The activities of 5 alpha-reductase and 3 alpha (beta)-hydroxysteroid dehydrogenase were assayed in homogenates of stroma and epithelium obtained from 3 normal, 9 hyperplastic and 2 carcinomatous human prostates. Irrespective of the normal or abnormal condition of the prostate, the localization of 5 alpha-reductase was predominantly in stroma whereas the reductive and oxidative activities of 3 alpha (beta)-hydroxysteroid dehydrogenase were more evenly divided between stroma and epithelium. Furthermore, the mean specific activity of 5 alpha-reductase in hyperplastic stroma at 84.6 plus or minus 13.1 (plus or minus SEM) pmol 30 min-1 mg protein-1 was almost 3 times greater (Student's t-test, P < 0.05) than the corresponding value in normal stroma, 31.6 plus or minus 7.2 pmol mg protein-1 30 min-1. We conclude that the stroma is the primary site of conversion of testosterone to dihydrotestosterone in the human prostate owing to the prevalence in stroma of 5 alpha-reductase, and that benign prostatic hyperplasia is characterized by an increased amount of stromal 5 alpha-reductase activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158242     DOI: 10.1530/acta.0.0940284

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Isolation and characterization of a novel human prostatic stromal cell culture: DuK50.

Authors:  K M Roberson; D W Edwards; G C Chang; C N Robertson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

2.  Challenges with luteinizing hormone-releasing hormone agonists: flare and surge.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2004

3.  Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2003

Review 4.  Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.

Authors:  Kalyan J Gangavarapu; Peter F Jowdy; Barbara A Foster; Wendy J Huss
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

5.  Increased activity of plasminogen activators during involution of the rat ventral prostate.

Authors:  P S Rennie; R Bouffard; N Bruchovsky; H Cheng
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

6.  The relationship between inhibition of plasminogen-activator activity and prostatic involution.

Authors:  P S Rennie; J F Bowden; N Bruchovsky; H Cheng
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

7.  Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis.

Authors:  N Wernert; J Gerdes; V Loy; G Seitz; O Scherr; G Dhom
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.